Akebia Therapeutics
AKBA
#7020
Rank
A$0.62 B
Marketcap
$2.88
Share price
3.30%
Change (1 day)
89.75%
Change (1 year)

P/S ratio for Akebia Therapeutics (AKBA)

P/S ratio as of November 2024 (TTM): 2.35

According to Akebia Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -12.2. At the end of 2024 the company had a P/S ratio of 1.23.

P/S ratio history for Akebia Therapeutics from 2014 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.232.07%
20231.20230.14%
20220.3636-80.36%
20211.8535.09%
20201.37-40.3%
20192.30-26.23%
20183.11-21.21%
20173.95-98.48%
2016260
2015N/A
2014N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.87 107.02%๐Ÿ‡บ๐Ÿ‡ธ USA
4.23 79.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
4.26 81.23%๐Ÿ‡บ๐Ÿ‡ธ USA
2.08-11.55%๐Ÿ‡บ๐Ÿ‡ธ USA